Laboratory Non Current Assets Total vs Non Current Liabilities Total Analysis

LH Stock

USD 194.91 1.47 0.76%

Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Non Current Assets Total and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Non Current Assets Total vs Non Current Liabilities Total

Non Current Assets Total vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Non Current Assets Total account and Non Current Liabilities Total. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Laboratory's Non Current Assets Total and Non Current Liabilities Total is 0.85. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Non Current Assets Total and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Laboratory of are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Non Current Assets Total i.e., Laboratory's Non Current Assets Total and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.85

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Non Current Liabilities Total

Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 7.8 B, while Selling General Administrative is projected to decrease to under 1.1 B.

	2021	2022	2023	2024 (projected)
Gross Profit	5.6B	4.4B	3.1B	1.9B
Total Revenue	16.1B	14.9B	12.2B	12.8B

Gross Profit Total Revenue

Laboratory fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.51	0.52	0.47	0.41	0.66	0.48	0.49	0.31	0.62	0.09	0.31	0.44	0.7	0.32	0.11	0.66	0.41	0.66	0.64	0.26	0.32	0.19	0.94	0.9
Total Assets	0.58		0.62	0.69	0.98	0.95	0.93	0.95	0.92	0.54	0.99	0.43	0.54	0.96	0.82	0.85	0.39	0.98	0.94	0.96	0.9	-0.01	0.85	0.76	0.57	0.32
Other Current Liab	0.51	0.62		0.81	0.65	0.55	0.45	0.68	0.47	0.53	0.6	0.53	0.53	0.68	0.53	0.4	-0.02	0.57	0.64	0.51	0.6	0.41	0.5	0.41	0.46	0.18
Total Current Liabilities	0.52	0.69	0.81		0.72	0.74	0.59	0.74	0.73	0.26	0.68	0.54	0.26	0.7	0.37	0.71	0.03	0.63	0.67	0.6	0.53	0.69	0.75	0.7	0.53	0.35
Total Stockholder Equity	0.47	0.98	0.65	0.72		0.96	0.84	0.98	0.92	0.56	0.95	0.53	0.56	0.99	0.72	0.87	0.28	0.92	0.97	0.88	0.83	0.0	0.91	0.84	0.48	0.19
Property Plant And Equipment Net	0.41	0.95	0.55	0.74	0.96		0.85	0.94	0.94	0.47	0.93	0.54	0.47	0.94	0.63	0.93	0.3	0.9	0.94	0.88	0.75	0.1	0.94	0.9	0.46	0.2
Net Debt	0.66	0.93	0.45	0.59	0.84	0.85		0.78	0.88	0.3	0.96	0.22	0.3	0.78	0.86	0.78	0.55	0.97	0.75	0.99	0.92	0.0	0.68	0.6	0.61	0.48
Retained Earnings	0.48	0.95	0.68	0.74	0.98	0.94	0.78		0.89	0.57	0.92	0.61	0.57	0.98	0.67	0.84	0.11	0.87	0.96	0.83	0.77	0.04	0.91	0.84	0.54	0.2
Accounts Payable	0.49	0.92	0.47	0.73	0.92	0.94	0.88	0.89		0.27	0.92	0.44	0.27	0.87	0.63	0.96	0.3	0.88	0.85	0.87	0.76	0.13	0.91	0.87	0.54	0.34
Cash	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27		0.47	0.36	1.0	0.63	0.52	0.24	0.04	0.5	0.7	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Non Current Assets Total	0.62	0.99	0.6	0.68	0.95	0.93	0.96	0.92	0.92	0.47		0.39	0.47	0.92	0.85	0.83	0.43	0.99	0.9	0.98	0.92	-0.01	0.81	0.72	0.59	0.37
Non Currrent Assets Other	0.09	0.43	0.53	0.54	0.53	0.54	0.22	0.61	0.44	0.36	0.39		0.36	0.55	0.23	0.44	-0.36	0.32	0.52	0.27	0.3	0.21	0.59	0.59	0.22	-0.17
Cash And Short Term Investments	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27	1.0	0.47	0.36		0.63	0.52	0.25	0.04	0.5	0.71	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Net Receivables	0.44	0.96	0.68	0.7	0.99	0.94	0.78	0.98	0.87	0.63	0.92	0.55	0.63		0.7	0.83	0.22	0.89	0.98	0.84	0.8	-0.02	0.9	0.81	0.47	0.14
Non Current Liabilities Total	0.7	0.82	0.53	0.37	0.72	0.63	0.86	0.67	0.63	0.52	0.85	0.23	0.52	0.7		0.48	0.46	0.88	0.67	0.88	0.96	-0.23	0.44	0.32	0.64	0.43
Other Current Assets	0.32	0.85	0.4	0.71	0.87	0.93	0.78	0.84	0.96	0.24	0.83	0.44	0.25	0.83	0.48		0.29	0.79	0.83	0.78	0.63	0.18	0.93	0.94	0.4	0.22
Other Stockholder Equity	0.11	0.39	-0.02	0.03	0.28	0.3	0.55	0.11	0.3	0.04	0.43	-0.36	0.04	0.22	0.46	0.29		0.48	0.23	0.52	0.51	-0.22	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.57	0.63	0.92	0.9	0.97	0.87	0.88	0.5	0.99	0.32	0.5	0.89	0.88	0.79	0.48		0.87	1.0	0.93	-0.03	0.76	0.66	0.63	0.43
Total Current Assets	0.41	0.94	0.64	0.67	0.97	0.94	0.75	0.96	0.85	0.7	0.9	0.52	0.71	0.98	0.67	0.83	0.23	0.87		0.83	0.75	-0.03	0.92	0.83	0.46	0.14
Short Long Term Debt Total	0.66	0.96	0.51	0.6	0.88	0.88	0.99	0.83	0.87	0.45	0.98	0.27	0.45	0.84	0.88	0.78	0.52	1.0	0.83		0.92	-0.04	0.73	0.63	0.63	0.46
Intangible Assets	0.64	0.9	0.6	0.53	0.83	0.75	0.92	0.77	0.76	0.45	0.92	0.3	0.45	0.8	0.96	0.63	0.51	0.93	0.75	0.92		-0.11	0.58	0.47	0.57	0.36
Short Term Debt	0.26	-0.01	0.41	0.69	0.0	0.1	0.0	0.04	0.13	-0.24	-0.01	0.21	-0.24	-0.02	-0.23	0.18	-0.22	-0.03	-0.03	-0.04	-0.11		0.18	0.19	0.26	0.32
Inventory	0.32	0.85	0.5	0.75	0.91	0.94	0.68	0.91	0.91	0.46	0.81	0.59	0.46	0.9	0.44	0.93	0.12	0.76	0.92	0.73	0.58	0.18		0.95	0.42	0.16
Property Plant And Equipment Gross	0.19	0.76	0.41	0.7	0.84	0.9	0.6	0.84	0.87	0.34	0.72	0.59	0.34	0.81	0.32	0.94	0.1	0.66	0.83	0.63	0.47	0.19	0.95		0.3	0.06
Common Stock	0.94	0.57	0.46	0.53	0.48	0.46	0.61	0.54	0.54	0.35	0.59	0.22	0.35	0.47	0.64	0.4	-0.1	0.63	0.46	0.63	0.57	0.26	0.42	0.3		0.87
Common Stock Total Equity	0.9	0.32	0.18	0.35	0.19	0.2	0.48	0.2	0.34	0.05	0.37	-0.17	0.05	0.14	0.43	0.22	0.07	0.43	0.14	0.46	0.36	0.32	0.16	0.06	0.87

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	98.6M	98M	97.5M	91.6M	87.6M	96.0M
Total Assets	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Other Current Liab	942.4M	1.4B	1.4B	1.1B	804M	502.9M
Total Current Liabilities	1.9B	2.6B	3.1B	2.8B	3.2B	3.4B
Total Stockholder Equity	7.6B	9.4B	10.3B	10.1B	7.9B	8.3B
Property Plant And Equipment Net	2.6B	2.7B	2.8B	3.0B	2.9B	3.1B
Net Debt	6.7B	5.4B	4.9B	5.9B	5.4B	5.7B
Retained Earnings	7.9B	9.4B	10.5B	10.6B	7.9B	8.3B
Accounts Payable	632.3M	638.9M	621.3M	934.8M	827.5M	868.9M
Cash	337.5M	1.3B	1.5B	430M	536.8M	290.8M
Non Current Assets Total	15.0B	14.9B	15.1B	15.5B	13.0B	13.6B
Non Currrent Assets Other	435.4M	410M	462.6M	432.7M	536.5M	270.8M
Cash And Short Term Investments	337.5M	1.3B	1.5B	430M	536.8M	299.7M
Net Receivables	2.0B	3.0B	3.0B	3.0B	2.1B	2.2B
Liabilities And Stockholders Equity	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Non Current Liabilities Total	7.8B	7.6B	7.3B	7.0B	5.6B	3.1B
Other Current Assets	373.7M	364.8M	478.1M	707M	655.3M	688.1M
Other Stockholder Equity	26.8M	110.3M	(192M)	(493.2M)	38.4M	36.5M
Total Liab	10.5B	10.7B	10.1B	10.1B	8.8B	9.3B
Total Current Assets	3.0B	5.1B	5.3B	4.6B	3.8B	4.0B
Short Long Term Debt Total	7.1B	6.8B	6.3B	6.3B	6.0B	6.3B
Intangible Assets	4.0B	4.0B	3.7B	3.9B	3.3B	2.0B
Short Term Debt	621.1M	575.4M	199M	492.8M	1.2B	1.2B
Inventory	244.7M	423.2M	401.4M	470.6M	474.6M	498.3M
Property Plant And Equipment Gross	2.6B	2.7B	5.2B	5.7B	5.8B	6.1B
Accumulated Other Comprehensive Income	(372.4M)	(161.9M)	(192M)	(493.2M)	(59.3M)	(62.3M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.8B	5.4B	5.4B	5.0B	4.1B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.9B	7.8B	8.0B	8.1B	6.1B	4.4B
Current Deferred Revenue	451M	506.5M	558.5M	582.1M	421.7M	442.8M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Currently Active Assets on Macroaxis

V	Visa Class A
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.

	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon

Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.123

Dividend Share

2.88

Earnings Share

4.68

Revenue Per Share

142.986

Quarterly Revenue Growth

0.046

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Non Current Assets Total vs Non Current Liabilities Total Analysis

Non Current Assets Total vs Non Current Liabilities Total

Non Current Assets Total vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Non Current Assets Total

Non Current Liabilities Total

Laboratory fundamental ratios Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Laboratory Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Assets Total	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Stockholder Equity
Short Long Term Debt Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.36	Non Currrent Assets Other
Short Term Debt	- 0.24	Cash And Short Term Investments
Short Term Debt	- 0.24	Cash
Short Term Debt	- 0.23	Non Current Liabilities Total
Short Term Debt	- 0.22	Other Stockholder Equity
Common Stock Total Equity	- 0.17	Non Currrent Assets Other